Vincerx Inc (VINC) Cotización

VINC, new 52 week low

VINC, new 52 week low

Great Reverse-Merger News (see the link below) today! The bid is already up to $1.31 so far!

https://finance.yahoo.com/news/vincerx-pharma-announces-non-binding-125200530.html

Based on the $15 Millions dollars of Buy-Out deal above and 2,239,580 shares Super TINY OS count, each common share of VINC is worthy $6.7! So, it might test its most recent high $10.4 again as soon as today...

VINC has $5.43 a share POSITIVE Huge Book Value NASDAQ Bio-Tech v.s. it is trading at as low as $0.75 (i.e. the RATIO of Book Value over the Stock Price was as High as Eye-Popping High 7.24), LOL! Even the company liquidates now its stock's valuation will be worthy Over $4 a share at least!

So, it will be Very Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value $5.43!

Note, on January 16, 2025, VINC did bounce up to $3.502 in the After-Hours session!

So, this Hidden Gem (VINC) is Super Undervalued now!

Also, this Diamond-In-Rough (VINC) is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.75!

Could anyone explain why a $5.43 a share POSITIVE Huge Book Value NASDAQ Bio-Tech stock was trading at as low as $0.75 (i.e. the RATIO of Book Value over the Stock Price was as High as Eye-Popping High 7.24)? Why is it? Even the company liquidates now its stock's valuation will be worthy Over $4 a share at least!

So, it will be Very Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value [color=green]$5.43!

Note, on January 16, 2025, VINC did bounce up to $3.502 in the After-Hours session!

Based on the Minimal $14.16 Millions dollars of Buy-Out deal below and 2,239,580 shares Super TINY OS count, each common share of VINC is worthy $6.323!

https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h

So, this Hidden Gem (VINC) is Super Undervalued now!

Also, this Diamond-In-Rough (VINC) is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.75!

VINC...8755... https://schrts.co/zWsXfSuN ...Reversal Candle setting up here...🥳

Vincerx where does this company go after the cancellation of the merger? Bankruptcy?

vinc...............................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783

Thats not bad news but I don't find it good news. The market is still looking at the stock price.

VINC just released a Good News in After-Hours after the market close --- see the link below!

https://ih.advfn.com/stock-market/NASDAQ/vincerx-VINC/stock-news/95460166/form-8-k-current-report

On February 11, 2025, Vincerx Pharma, Inc. (the “Company”) received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share. Nasdaq notified the Company in the Compliance Notice that, from January 28, 2025 to February 10, 2025, the closing bid price of the Company’s common stock had been $1.00 per share or greater and, accordingly, the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter was now closed.

The POSITIVE Huge Book Value is $5.43 a share vs. the stock is trading at Ridiculous-Low price levels $1.28 now, LOL! Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value!

Note, on January 16, 2025, VINC did bounce to $3.502 in the After-Hours session!

Every common share of VINC is worthy $6.323 based on the Minimal $14.16 Millions dollars of Buy-Out deal and 2,239,580 shares Super Tiny OS count!

https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h

This Diamond-In-Rough is at Hyper Oversold status --- from 12/30/2024's $10.4 to New Bottom $1.18!

So, this Hidden Gem is Super Undervalued now!

VINC under $2

VINC: But heck, I'd bet that if you indeed DID do that, such would surely entail a person-to-person PHONECON with your WeBull(?) broker, Dude!!

It is Super Hard to understand why this Hidden Gem has $5.4286 per share Huge POSITIVE Book Value but it is trading at such Ridiculous-Low or Huge Discount price levels $1.3x ~ $1.4x?

If I had $3,045,828.80 cash at hand then I'm willing to Buy-Out the Entire OS at current Huge Discount Dirt Cheap price $1.36 because 2,239,580 x $1.36 = $3,045,828.80!

VINC: THANKS for both heads-ups!!

Very Good News just kicked in on After-Hour (see the link below)! Each common share is worthy $6.3226141 based on the Minimal $14.16 Millions dollars Buy-Out deal and 2,239,580 shares Super Tiny OS count!

https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h

So, VINC is Super Undervalued now just like its Red-Hot Bitcoin-Mining peer (VTXB is worthy Multiple Pennies a share at least)! Easy to surge over last-December-high $10.4!

Also, VINC is at Hyper Oversold status (from $187.444 to $1.3101) just like its Red-Hot Bitcoin-Mining peer (from $0.06 to $0.0001)!

VINC just hit New Premarket-High $1.83 on the early morning trading session! It will test January 28's Premarket-High $3.35 or even January 16's After-Hour-High $3.502 in the coming days/weeks...

VINC is at Hyper Oversold status now --- from 12/30/2024's high $10.4 to 01/30/2025's low $1.40!

VINC is Extremely Undervalued now based on its Much-Much-Higher Positive Book Value!

Only Mere 2,239,580 shares of the Tiny OS! Easy to surge over $4.00! It is possible for VINC to hit its most recent high $10.4 again!

VINC...$1.69...🥳

georgie18

Member Level
Re: None

Saturday, February 01, 2025 3:12:37 PM

Post#
31347
of 31358
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...

georgie18

Member Level
Re: georgie18 post# 31

Wednesday, January 29, 2025 8:28:50 AM

Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...

georgie18

Member Level
Re: georgie18 post# 31

Wednesday, January 29, 2025 8:28:50 AM

Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC had finally Bottomed Out at New 52-week-low $1.4 yesterday with the After-Hour-high $1.7! It should test January 28's Premarket-High $3.35 or even January 16's After-Hour-High $3.502 in the coming days/weeks...

Note, the most recent high was $10.4!

VINC............................https://stockcharts.com/h-sc/ui?s=VINC&p=W&b=5&g=0&id=p86431144783

VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html

georgie18

Member Level
Re: georgie18 post# 387642

Friday, December 27, 2024 4:35:45 PM

Post#
387643
of 389318
VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC: That news seems impressive.
https://finance.yahoo.com/news/vincerx-pharma-inc-oqory-inc-130000038.html

VINC soared to $3.35 so far after Very Good News 9see the link below) from New low $1.62!

https://finance.yahoo.com/news/vincerx-pharma-inc-oqory-inc-130000038.html

This Big-R/S Pos Scam may test $3.502 (i.e. Pre-1:20 R/S's $0.1751) today...

VERY SICK CEO is a Super Crap man and deserves to go to the jail forever!!! Because he has destroyed all the Pre-R/S investors! Never trust this sick man again! Fuck the CEO!!

$2.56 *+58% About Proposed Merger

You love it today was too quick + 80% $2.90 

VINC: Love it!!!

Wow, VINC bounced up to $0.15 this early morning (01/23/25) and it also bounced up to $0.1751 just a couple of days ago (After-Hour session of 01/16/25)!

It has Very POSITIVE Book Value --- $0.27 per share! So, it is currently Extremely Undervalued! Easy to surge back to $0.3xxx again!

VINC is also at Extremely Oversold status --- from last-month-high $0.52 (12/30/24) to current Ridiculous-Low price levels $0.1xxx!

Why 10-Bagger here? Another New 52-week-low $0.1395 was created yesterday after Heavy Sell-Off and Manipulation Sales! Who have dumped so many shares below its previous 52-week-low $0.1754?

Why VINC crashed from last-month-high $0.52 during the past a couple of weeks? Whoever bought it most recently at $0.52 ~ $0.42 will be never able to make even or make profit in the future!

It seems Bottomed out at $0.1395 anyway!

Another New 52-week-low $0.145 was just created today! We'll see Another New 52-week-low $0.13 as soon as tomorrow...

VINC will be forced to file the Coming Inevitable CH11 or even CH7 BANKRUPTCY very soon! Whoever bought this Pos Scam most recently at $0.52 ~ $0.39 will never have a chance to get positive investment return in the future!

We should see this trash further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the near future!

Another New 52-week-low $0.165 was just created today! We'll see Another New 52-week-low $0.15 as soon as tomorrow...

VINC will be forced to file the Coming Inevitable CH11 or even CH7 BANKRUPTCY very soon! Who ever bought this Pos Scam at $0.52 ~ $0.2 most recently? They are very super stupid!

We should see this trash further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the near future!

The Soon-Bankruptcy Pos Scam declined to $0.1828 (which is just mere $0.0074 higher than its 52-week-low $0.1754) last Friday!

We should see it further crash to $0.025 before the Coming Inevitable Huge R/S (1:100 ~ 1:1000) in the coming days/weeks...

Note, the WORTHLESS Bitcoin just declined to $90K and will soon crash to $5K!

Who said every third tier NASDAQ stock was the next MICROSOFT

Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the seventh, eighth, and nineth Bad news for VINC:

"SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates VINC, MHLD, NEUE on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3095233

"Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3098961

"Up to 1:20 Big R/S" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18036191&guid=Qs0-kKDmXUvnJth

"16,356,210 shares of Huge New FREE dilutions" --- see the link below for the details.
https://www.otcmarkets.com/filing/html?id=18074105&guid=Qs0-kKDmXUvnJth

So, we should see A Series Of New 52-Week-Lows until VINC hits the Final Bottom $0.025...

Are you kidding? "The next Misrosoft|? No way! The best situation is to avoid to file the BANKRUPTCY! I wish "No Bankruptcy" here so that we could see a "Dead-Cat Bounce" sometime this year!

Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the fourth, fifth, and sixth Bad news for VINC:

"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN, VINC, OMIC on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089437

"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VINC, NEUE, ZUO on Behalf of Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3092088

"VINCERX PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Vincerx Pharma, Inc. - VINC" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3093920

Liquidate the Pos Scam ASAP! Because there are A Series Of Bad News about the company! Here are the first, second, and third Bad news for VINC:

"Shareholder Alert: Ademi LLP Investigates Whether Vincerx Pharma, Inc. Is Obtaining a Fair Price for Its Public Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087853

"VINC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Vincerx Pharma, Inc. Is Fair to Shareholders" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3087906

"STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - VINC, VCSA, MRNS, MHLD" --- see the link below for the details.
https://www.otcmarkets.com/stock/VINC/news/story?e&id=3089161

VINC: To dah MOOOOOOOON!!!

vinc....................https://stockcharts.com/h-sc/ui?s=vinc&p=W&b=5&g=0&id=p86431144783

We shall see…🥳

Got in the mid 30,s after the drop,I wonder if there might be another spike up Monday morning

10 bagger imo

VINC...40s clearing here...🥳

georgie18

Member Level
Re: georgie18 post# 29

Friday, December 27, 2024 4:19:41 PM

Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.

Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.

georgie18

Member Level
Re: georgie18 post# 386297

Monday, December 09, 2024 4:01:30 PM

Post#
386750
of 387642
VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC...2194...added here today...🥳

georgie18

Member Level
Re: None

Monday, December 02, 2024 9:42:03 AM

Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC...2954...🥳...Trying to Reverse here to the Upside...

VINC .84 + 20% …05:05 PM EDT, 10/07/2024 (MT Newswires) -- Vincerx Pharma (VINC) said its VIP943 leukemia drug showed "promising safety and tolerability," achieving two complete responses to date in a phase 1 dose-escalation study

The VIP943 antibody-drug conjugate is being evaluated in relapsed/refractory acute myeloid leukemia, higher-risk myelodysplastic syndrome and B-cell acute lymphoblastic leukemia, the company said Monday in a statement.

Another data update is expected by the end of the year, the company said.

In an update on VIP236 being evaluated in a first-in-human, phase 1 dose-escalation study as a monotherapy in patients with advanced solid tumors, the company said it intends to pursue a strategic partner to "champion its future development" in order to focus on VIP943.

Vincerx expects a cash runway into early 2025.

Shares of the company jumped 15% in after-hours activity.

Price: 0.8000, Change: +0.10, Percent Change: +

What a cluster this stock has become.
Unreal actually. $0.60 to $10 back to $0.60 all within 4 months.
Can’t believe they didn’t try to do the financing when it was trading above $5.

Tomorrow will be $1.50

No news on dilution yet. When will we see a rebound? Seeking money being lost is the painful part of life

Blood bath. I should have waited one more day.

Somebody knows something you don’t

I don’t find the price and volume the capital raise is. Am I missing anything here?